IndraLab

Statements

USP51 deubiquitinates Parkinson Disease on L1. 2 / 2

| 2

➶

reach

"Indeed, USP51 was able to deubiquitinate PD‐L1 at either K280 or K281 lysine residue (Figure 5H)."

37386737

➶

reach

"Consistently, the ubiquitination assay revealed that USP51 deubiquitinase inhibition by treatment with DHM led to increased polyubiquitination of PD‐L1 proteins in USP51/A549 cells (Supplementary Figure S20B)."

37386737

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP51 deubiquitinates Parkinson Disease on L1. 2 / 2

INDRA sources:

Databases

Reading